Keywords: ALK; anaplastic lymphoma kinase; DCTN1; dynactin 1; EGFR; epidermal growth factor receptor; EML4; microtubule-associated protein-like 4; FISH; fluorescence in situ hybridization; GLCI; Guangdong Lung Cancer Institute; HELP; hydrophobic EMAP-like protein;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Targeted receptor TKIs; Acquired resistance to receptor TKIs; Overcoming drug resistance; Driver oncogenes; Gate keeper receptor mutations; Bypass signaling molecules; ABC; ATP-binding cassette; AKT/PKB; Protein kinase B; ALK; Anaplastic lymphoma kinase;
Keywords: ALK; EML4; Oesophageal cancer; Translocation; Amplification; STAT3;
Bioanalytical assay for the quantification of the ALK inhibitor lorlatinib in mouse plasma using liquid chromatography-tandem mass spectrometry
Keywords: ALK; anaplastic lymphoma kinase; EMA; European Medicines Agency; EML4; echinoderm microtubule-associated protein-like 4; ESI; electro spray ionization; FDA; Food and Drug Administration; IS; internal standard; LC-MS/MS; liquid chromatography-tandem mass s
Scaffold hopping identifies 6,8-disubstituted purines as novel anaplastic lymphoma kinase inhibitors
Keywords: ALK; anaplastic lymphoma kinase; cMet; hepatocyte growth factor receptor; DIPEA; N,N-Diisopropylethylamine; DMF; N,N-Dimethylformamide; EML4; echinoderm microtubule-associated protein-like 4; FDA; food and drug administration; gk; gatekeeper; μW; micro w
Concomitance of EGFR mutations and ALK rearrangement in patients with Lung Cancer
Keywords: ALK; Anaplastic lymphoma kinase; EGFR; Epithelial growth factor receptor; EML4; Echinoderm Microtubule Associated Protein Like 4; K-Ras; Kirsten rat sarcoma viral; MAPK; Mitogen-activated protein kinases; NSCLCs; Non-small cell lung cancers; PI3K; Phospha
Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2)
Keywords: ABC; ATP-binding cassette; ALK; anaplastic lymphoma kinase; AUC; area under the plasma concentration-time curve; BBB; blood-brain barrier; BCRP; breast cancer resistance protein; Cmax; maximum drug concentration in plasma; EML4; echinoderm microtubule-ass
Personalized Oncology in Interventional Radiology
Keywords: ATP; adenosine triphosphate; ALK; analplastic lymphoma factor; BCR-ABL; breakpoint cluster region/the Abelson tyrosine; BRAF; v-raf murine sarcoma viral oncogene; CD-20; clusters of differentiation-20 (antigen of B-cells); c-KIT; tyrosine-protein kinase k
ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity
Keywords: ALK; EML4; KIF5B; Fusion gene; Lung cancer; EBUS; TBNA; Crizotinib; ALK inhibitor;
EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas
Keywords: EML4; ALK; Fusion gene; Non-small cell lung carcinoma; p53; EGFR
Human EML4, a novel member of the EMAP family, is essential for microtubule formation
Keywords: Microtubule-associated protein; EMAP; EMAP-like proteins; EML4; Phosphorylation; Cell cycle